Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.46% is 14% below its 5-year average of 0.54%, around the middle of its 5-year range (0.09%–0.96%).
As of the fiscal period ended Tuesday, June 30, 2026. 34.30% below its 12-month average of 0.70%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.46%.
DEBT TO ASSETS RATIO
0.46%
DEBT TO ASSETS RATIO AVG TTM
0.70%
DEBT TO ASSETS RATIO AVG 3Y
0.71%
DEBT TO ASSETS RATIO AVG 5Y
0.54%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-34.30%
CURRENT VS 3Y AVG
-34.59%
CURRENT VS 5Y AVG
-13.81%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 595 covered companies
CURRENT VS SECTOR MEDIAN
+361.68%
vs the sector median at left
Lantern Pharma Inc.
Market Cap
$11.87M
Debt to Assets Ratio
0.46%
TTM Avg
0.70%
3Y Avg
0.71%
5Y Avg
0.54%
Market Cap
$11.85M
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.63M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.50M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.38M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.46M
Debt to Assets Ratio
0.30%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.17M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lantern Pharma Inc. (LTRN) | $11.87M | 0.46% | 0.70% | 0.71% | 0.54% |
| Cytosorbents Corporation (CTSO)vs › | $11.85M | 0.69% | N/A | N/A | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.63M | 0.01% | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.50M | 0.00% | N/A | N/A | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.38M | 0.00% | N/A | N/A | N/A |
| IRIDEX Corporation (IRIX)vs › | $12.41M | 0.15% | N/A | N/A | N/A |
| Dare Bioscience, Inc. (DARE)vs › | $12.46M | 0.30% | N/A | N/A | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.26M | 0.31% | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.17M | 0.01% | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $10.95M | 0.02% | N/A | N/A | N/A |
Debt/Assets
0.5%
Debt/Equity
N/A
Current Ratio
1.96
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.46% |
| 2026-03-31 | 0.82% |
| 2025-12-31 | 0.71% |
| 2025-09-30 | 0.69% |
| 2025-06-30 | 0.83% |
| 2025-03-31 | 0.92% |
| 2024-12-31 | 0.95% |
| 2024-09-30 | 0.96% |
| 2024-06-30 | 0.61% |
| 2024-03-31 | 0.49% |
| 2023-12-31 | 0.54% |
| 2023-09-30 | 0.57% |
| 2023-06-30 | 0.61% |
| 2023-03-31 | 0.47% |
| 2022-12-31 | 0.09% |
| 2022-09-30 | 0.15% |
| 2022-06-30 | 0.20% |
| 2022-03-31 | 0.25% |
| 2021-12-31 | 0.28% |
| 2021-09-30 | 0.31% |
| 2021-06-30 | 0.34% |
| 2021-03-31 | 0.13% |
| 2020-12-31 | 0.53% |
| 2020-09-30 | 0.48% |
| 2020-06-30 | 0.83% |
| 2020-03-31 | 5.13% |
| 2019-12-31 | 0.00% |
